Companies

STERIS plc

STE · CIK 0001757898 · operating

$248.94-1.35%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$24.32B
P/E34.56
Fwd P/E22.33
PEG
P/S4.17
P/B3.40
EV/EBITDA16.76
EV/Rev4.53

Profitability

Gross Margin44.01%
Op. Margin15.87%
Net Margin11.26%
ROE9.31%
ROA6.06%
FCF Margin14.25%

Financial Health

Current Ratio1.96
Debt/Equity0.53
Free Cash Flow$778.00M
Div. Yield0.97%

Growth & Other

Revenue Growth284.64%
EPS Growth62100.00%
Beta1.04
52W High$269.44
52W Low$204.9

About STERIS plc

STERIS plc operates in infection prevention and sterilization across healthcare, pharmaceutical, and medical device manufacturing sectors. The company designs and manufactures cleaning chemistries, sterilization equipment, and sterility assurance products used in hospital sterile processing departments and procedure rooms. Its product portfolio includes automated endoscope reprocessing systems, surgical tables, operating room lighting and connectivity solutions, capital equipment for sterilization facilities, and consumable sterilants and disinfectants. The company also provides equipment installation, maintenance, repair, and custom process improvement consulting services.

The business is organized into three segments. The Healthcare segment supplies sterile processing equipment and services to hospitals and healthcare facilities, including reprocessing systems, washers, sterilizers, and room equipment alongside maintenance and repair services. The Applied Sterilization Technologies segment operates contract sterilization and testing facilities for medical device and pharmaceutical manufacturers, complemented by sterilization equipment sold directly to industrial customers. The Life Sciences segment manufactures consumables such as pharmaceutical detergents, cleanroom disinfectants, vaporized hydrogen peroxide sterilization systems, and high purity water generators, with supporting equipment services.

STERIS employs approximately 17,787 people and operates sterilization and laboratory facilities across multiple geographies. Incorporated in Ireland with headquarters in Mentor, Ohio, the company serves hospitals, healthcare providers, and pharmaceutical manufacturers globally.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$6.20$6.24+62100.0%
2024$-0.01$-0.01-100.9%
2023$1.07$1.07+105.8%
2022$0.52$0.52-49.0%
2021$1.02$1.02-29.2%
2020$1.44$1.45+13.4%
2019$1.27$1.29

Annual Reports (10-K) · 7 filings

Report DateFiledAccession Number
2025-03-312025-05-290001757898-25-000005SEC ↗
2024-03-312024-05-290001757898-24-000008SEC ↗
2023-03-312023-05-260001757898-23-000005SEC ↗
2022-03-312022-05-310001757898-22-000011SEC ↗
2021-03-312021-05-280001757898-21-000017SEC ↗
2020-03-312020-05-290001757898-20-000012SEC ↗
2019-03-312019-05-300001757898-19-000005SEC ↗